RYAN MUTH: Open Payments
NPI 1932624350 · CARMEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 38 payments from 15 companies in 2025. Trend: 2023 $495 · 2024 $548 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $203 |
| Actelion Pharmaceuticals US, Inc. | 4 | $108 |
| Amgen Inc. | 3 | $79 |
| Lilly USA, LLC | 3 | $64 |
| PFIZER INC. | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Cleerly, Inc. | 1 | $27 |
Products named: VRAYLAR, OPSUMIT, EVENITY, MOUNJARO, NURTEC ODT, QULIPTA, Auvelity, Adempas.
Industry payments across CA — which companies pay providers there.
